LNTH - Lantheus Holdings Inc Stock Price, Fair Value and News

65.21USD+0.80 (+1.24%)Market Closed

Market Summary

USD65.21+0.80

Market Closed

1.24%

LNTH Alerts

1 major insider sales recently.

LNTH Stock Price

View Fullscreen

LNTH RSI Chart

LNTH Valuation

Market Cap

4.4B

Price/Earnings (Trailing)

13.51

Price/Sales (Trailing)

3.4

EV/EBITDA

8.68

Price/Free Cashflow

14.46

LNTH Price/Sales (Trailing)

LNTH Profitability

EBT Margin

31.70%

Return on Equity

40.04%

Return on Assets

19.78%

Free Cashflow Yield

6.92%

LNTH Fundamentals

LNTH Revenue

Revenue (TTM)

1.3B

Rev. Growth (Yr)

34.52%

Rev. Growth (Qtr)

10.64%

LNTH Earnings

Earnings (TTM)

326.7M

Earnings Growth (Yr)

186.74%

Earnings Growth (Qtr)

-21.66%

Breaking Down LNTH Revenue

Last 7 days

4.3%

Last 30 days

9.1%

Last 90 days

26.1%

Trailing 12 Months

-29.4%

How does LNTH drawdown profile look like?

LNTH Financial Health

Current Ratio

5.8

Debt/Equity

0.69

Debt/Cashflow

0.54

LNTH Investor Care

Shares Dilution (1Y)

1.46%

Diluted EPS (TTM)

4.64

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	1.0B	1.1B	1.2B	1.3B
2022	541.6M	664.2M	801.5M	935.1M
2021	341.2M	376.3M	389.8M	425.2M
2020	351.5M	331.8M	334.6M	339.4M
2019	347.3M	347.4M	344.3M	347.3M
2018	332.6M	329.4M	338.3M	343.4M
2017	306.7M	317.6M	324.5M	331.4M
2016	295.1M	299.8M	298.7M	301.9M
2015	303.1M	300.8M	299.2M	293.5M
2014	0	289.6M	295.6M	301.6M
2013	0	0	0	283.7M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Lantheus Holdings Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 17, 2024	blanchfield paul	sold (taxes)	-27,973	61.48	-455	president
Apr 15, 2024	sabens andrea	sold	-20,882	61.24	-341	chief accounting officer
Mar 15, 2024	marshall robert j. jr.	sold	-1,200,000	60.00	-20,000	cfo and treasurer
Mar 13, 2024	sabens andrea	sold	-20,623	60.48	-341	chief accounting officer
Mar 07, 2024	blanchfield paul	sold	-1,116,710	61.96	-18,023	president
Mar 07, 2024	blanchfield paul	gifted	-	-	-500	president
Mar 06, 2024	leno sam r	acquired	33,333	16.3	2,045	-
Mar 06, 2024	leno sam r	sold	-129,857	63.4999	-2,045	-
Mar 05, 2024	leno sam r	sold	-132,148	64.6199	-2,045	-
Mar 05, 2024	blanchfield paul	sold (taxes)	-1,354,780	65.36	-20,728	president

Which funds bought or sold LNTH recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 22, 2024	MetLife Investment Management, LLC	reduced	-0.78	-586,462	4,529,910	0.03%
Apr 22, 2024	Raymond James Financial Services Advisors, Inc.	added	94.93	238,723	488,211	-%
Apr 22, 2024	RAYMOND JAMES & ASSOCIATES	added	29.67	260,391	1,123,430	-%
Apr 19, 2024	State of Alaska, Department of Revenue	unchanged	-	2,000	460,000	-%
Apr 19, 2024	Legacy Wealth Asset Management, LLC	added	19.94	100,304	591,840	0.16%
Apr 19, 2024	VALLEY NATIONAL ADVISERS INC	new	-	1,000	1,000	-%
Apr 18, 2024	Phocas Financial Corp.	unchanged	-	-5,772,220	5,778	0.02%
Apr 18, 2024	STATE OF MICHIGAN RETIREMENT SYSTEM	added	2.44	28,832	1,045,630	0.01%
Apr 18, 2024	Oliver Luxxe Assets LLC	new	-	546,903	546,903	0.12%
Apr 18, 2024	Allspring Global Investments Holdings, LLC	added	25.91	1,144,550	5,479,990	0.01%

Are Funds Buying or Selling LNTH?

Are funds buying LNTH calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own LNTH

No. of Funds

LNTH Alerts

1 major insider sales recently.

Unveiling Lantheus Holdings Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 14, 2024	janus henderson group plc	5.8%	3,962,606	SC 13G
Feb 13, 2024	vanguard group inc	10.18%	6,973,141	SC 13G/A
Jan 23, 2024	blackrock inc.	12.6%	8,600,964	SC 13G/A
Feb 10, 2023	blackrock inc.	11.9%	8,213,720	SC 13G/A
Feb 09, 2023	vanguard group inc	10.53%	7,247,124	SC 13G/A
Jan 26, 2023	blackrock inc.	11.9%	8,203,470	SC 13G/A
Jan 20, 2023	blackrock inc.	11.9%	8,203,470	SC 13G/A
Jul 11, 2022	vanguard group inc	10.84%	7,438,724	SC 13G/A
Feb 15, 2022	armistice capital, llc	0%	0	SC 13G/A
Feb 14, 2022	price t rowe associates inc /md/	3.1%	2,165,371	SC 13G/A

Recent SEC filings of Lantheus Holdings Inc

View All Filings

Date Filed	Form Type	Document
Apr 19, 2024	4	Insider Trading
Apr 17, 2024	4	Insider Trading
Apr 15, 2024	144	Notice of Insider Sale Intent
Apr 04, 2024	3	Insider Trading
Mar 19, 2024	4	Insider Trading
Mar 15, 2024	144	Notice of Insider Sale Intent
Mar 15, 2024	4	Insider Trading
Mar 15, 2024	ARS	ARS
Mar 15, 2024	DEF 14A	DEF 14A
Mar 15, 2024	DEFA14A	DEFA14A

Peers (Alternatives to Lantheus Holdings Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	360.2B	85.2B	-3.67%	-8.64%	10.25	4.23	6.46%	95.94%
MRK	321.4B	60.1B	2.46%	9.45%	880.53	5.35	1.40%	-97.49%
PFE	148.6B	46.5B	-3.80%	-34.05%	-107.04	3.19	42.59%	-114.62%
AMGN	146.6B	28.2B	-0.95%	11.90%	21.82	5.2	7.09%	2.52%
GILD	83.5B	27.1B	-7.68%	-22.69%	14.74	3.08	-0.60%	23.36%
TEVA	14.6B	15.8B	-6.26%	55.93%	-25.32	0.92	6.17%	76.47%
MID-CAP
PRGO	4.1B	4.7B	-2.65%	-15.52%	-325.34	0.89	4.58%	90.97%
ALKS	4.1B	1.7B	-11.07%	-16.83%	11.39	2.44	49.61%	324.78%
BHC	3.1B	8.8B	-10.77%	12.83%	-5.27	0.36	7.79%	-163.11%
AMPH	2.0B	644.4M	-6.43%	-0.05%	14.31	3.05	29.14%	50.51%
SMALL-CAP
TLRY	1.4B	743.2M	-20.35%	-21.70%	-4.05	1.92	24.65%	80.36%
TXMD	21.7M	1.3M	-17.90%	-49.19%	-2.11	16.65	-98.14%	-109.18%
ACRX	16.3M	-	-14.29%	38.83%	-0.89	0.22	2882.68%	-138.52%
AGRX	2.5M	19.6M	-32.73%	-94.43%	-0.18	0.13	80.00%	43.08%
ACOR	645.9K	117.6M	-96.48%	-95.45%	0	0.01	-0.79%	-283.60%

Lantheus Holdings Inc News

Latest updates

Lantheus Holdings Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	10.6%	354	320	322	301	263	239	224	209	130	102	101	93.00	94.00	89.00	66.00	91.00	89.00	86.00	86.00	87.00	86.00
Gross Profit	15.0%	230	200	203	77.00	167	147	138	129	58.00	43.00	46.00	41.00	39.00	36.00	26.00	38.00	45.00	42.00	45.00	44.00	44.00
S&GA Expenses	-5.7%	35.00	37.00	36.00	33.00	27.00	25.00	27.00	20.00	19.00	17.00	18.00	14.00	13.00	12.00	6.00	10.00	10.00	10.00	11.00	10.00	10.00
R&D Expenses	16.4%	17.00	14.00	16.00	31.00	272	13.00	15.00	12.00	11.00	11.00	12.00	10.00	13.00	12.00	4.00	4.00	4.00	5.00	6.00	5.00	5.00
EBITDA Margin	167.4%	0.38*	0.14*	0.08*	0.02*	0.09*	0.27*	0.17*	0.04*	-0.06*	0.03*	0.05*	0.11*	-	-	-	-	-	-	-	-	-
Interest Expenses	-0.3%	5.00	5.00	5.00	5.00	3.00	2.00	1.00	2.00	2.00	2.00	2.00	3.00	3.00	3.00	2.00	2.00	2.00	2.00	5.00	5.00	5.00
Income Taxes	25.1%	35.00	28.00	30.00	-8.30	-57.06	22.00	19.00	15.00	-0.79	-6.42	-1.88	5.00	1.00	-1.08	0.00	2.00	-8.05	1.00	2.00	3.00	4.00
Earnings Before Taxes	-13.5%	138	160	124	-11.10	-176	83.00	62.00	58.00	-41.01	-19.84	-28.54	14.00	-2.84	-7.46	-6.70	6.00	2.00	5.00	8.00	13.00	13.00
EBT Margin	296.8%	0.32*	0.08*	0.02*	-0.04*	0.03*	0.20*	0.09*	-0.06*	-0.18*	-0.09*	-0.07*	-0.01*	-	-	-	-	-	-	-	-	-
Net Income	-21.7%	103	132	94.00	-2.81	-119	61.00	43.00	43.00	-40.22	-13.41	-26.66	9.00	-3.41	-6.39	-7.01	3.00	10.00	5.00	6.00	10.00	13.00
Net Income Margin	191.8%	0.25*	0.09*	0.03*	-0.02*	0.03*	0.13*	0.05*	-0.07*	-0.17*	-0.09*	-0.07*	-0.02*	-	-	-	-	-	-	-	-	-
Free Cashflow	-3.8%	112	117	-32.27	109	105	94.00	73.00	10.00	14.00	4.00	26.00	10.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	8.5%	1,651	1,522	1,338	1,349	1,321	1,096	1,014	933	864	848	858	843	870	880	880	404	406	402	390	444	440
Current Assets	14.5%	1,086	948	752	773	678	502	404	325	236	202	186	168	184	185	181	180	173	154	140	195	195
Cash Equivalents	16.2%	714	614	414	471	416	257	171	105	99.00	91.00	92.00	69.00	83.00	88.00	90.00	96.00	93.00	78.00	57.00	112	113
Inventory	13.4%	64.00	56.00	52.00	42.00	35.00	35.00	34.00	34.00	35.00	34.00	32.00	30.00	36.00	38.00	35.00	31.00	29.00	31.00	32.00	32.00	33.00
Net PPE	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	109	116	114	113	112	108
Goodwill	0%	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	61.00	59.00	58.00	45.00	16.00	16.00	16.00	16.00	16.00	16.00
Liabilities	1.5%	835	823	785	904	874	458	446	417	399	348	350	315	356	366	364	286	291	301	298	361	369
Current Liabilities	6.1%	187	177	154	276	248	236	219	178	90.00	77.00	74.00	65.00	81.00	82.00	76.00	62.00	66.00	60.00	53.00	43.00	53.00
Long Term Debt	0.2%	562	561	559	559	558	152	156	159	163	167	169	171	198	205	210	181	184	186	189	263	264
LT Debt, Current	17.1%	1.00	1.00	0.00	0.00	0.00	15.00	14.00	13.00	12.00	10.00	10.00	10.00	21.00	18.00	17.00	10.00	10.00	10.00	10.00	3.00	3.00
LT Debt, Non Current	-	-	-	-	-	558	-	-	-	163	-	-	171	198	205	210	181	184	186	189	263	264
Shareholder's Equity	16.8%	816	699	553	446	447	638	567	516	464	499	508	528	514	514	516	118	115	101	92.00	83.00	71.00
Retained Earnings	343.2%	134	30.00	-101	-195	-193	-73.97	-135	-178	-221	-181	-167	-140	-149	-146	-140	-133	-136	-146	-151	-158	-168
Additional Paid-In Capital	1.8%	758	744	730	717	716	708	700	692	685	681	676	670	666	662	658	254	252	249	245	242	240
Shares Outstanding	0.1%	70.00	70.00	70.00	70.00	69.00	69.00	68.00	68.00	67.00	68.00	68.00	-	-	-	-	-	-	-	-	-	-
Float	-	-	-	5,673	-	-	-	4,487	-	-	-	1,850	-	-	-	947	-	-	-	1,091	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-3.8%	112,287	116,739	-32,266	108,500	105,352	93,568	72,597	10,264	13,889	4,340	25,869	9,818	569	8,575	-2,156	9,408	22,421	26,442	21,053	10,468	17,306
Share Based Compensation	1.4%	14,172	13,976	12,692	9,667	8,124	8,103	7,412	5,623	4,162	3,867	4,588	3,317	3,623	3,992	3,385	3,075	2,991	3,423	3,358	2,720	2,299
Cashflow From Investing	-114.5%	-12,069	83,218	-20,697	-44,513	-264,724	-6,090	-4,343	-1,390	-4,544	-2,420	-2,656	13,303	-3,785	-3,736	5,307	-2,698	-4,741	-3,336	-3,434	-10,550	-7,366
Cashflow From Financing	-516.7%	-450	108	-4,051	-8,669	317,840	-1,959	-2,011	-2,179	-2,100	-1,726	-715	-34,791	-4,373	-7,270	-6,486	-3,732	-2,823	-1,900	-72,927	-1,231	-934

LNTH Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenues	$ 1,296,429	$ 935,061	$ 425,208
Cost of goods sold	586,886	353,358	237,513
Gross profit	709,543	581,703	187,695
Operating expenses
Sales and marketing	141,736	100,243	68,422
General and administrative	125,458	133,584	150,395
Research and development	77,707	311,681	44,966
Total operating expenses	344,901	545,508	263,783
Gain on sales of assets	0	0	15,263
Operating income (loss)	364,642	36,195	(60,825)
Interest expense	20,019	7,185	7,752
Loss (gain) on extinguishment of debt	0	588	(889)
Other (income) loss, net	(66,320)	1,703	7,350
Income (loss) before income taxes	410,943	26,719	(75,038)
Income tax expense (benefit)	84,282	(1,348)	(3,759)
Net income (loss)	$ 326,661	$ 28,067	$ (71,279)
Net income (loss) per common share:
Basic (in dollars per share)	$ 4.79	$ 0.41	$ (1.06)
Diluted (in dollars per share)	$ 4.65	$ 0.40	$ (1.06)
Weighted-average common shares outstanding:
Basic (in shares)	68,266	68,487	67,486
Diluted (in shares)	70,239	70,671	67,486

LNTH Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 713,656	$ 415,652
Accounts receivable, net	284,292	213,397
Inventory	64,029	35,475
Other current assets	16,683	13,092
Assets held for sale	7,159	0
Total current assets	1,085,819	677,616
Property, plant and equipment, net	146,697	122,166
Intangibles, net	151,985	315,285
Goodwill	61,189	61,189
Deferred tax assets, net	150,198	110,647
Other long-term assets	55,261	34,355
Total assets	1,651,149	1,321,258
Current liabilities
Current portion of long-term debt and other borrowings	823	354
Accounts payable	41,189	20,563
Short-term contingent liability	0	99,700
Accrued expenses and other liabilities	145,338	127,084
Total current liabilities	187,350	247,701
Asset retirement obligations	22,916	22,543
Total long-term debt, net, and other borrowings	561,670	557,712
Other long-term liabilities	63,321	46,155
Total liabilities	835,257	874,111
Commitments and contingencies (see Note 19)
Stockholders’ equity
Preferred stock ($0.01 par value, 25,000 shares authorized; no shares issued and outstanding)	0	0
Common stock ($0.01 par value, 250,000 shares authorized; 69,863 and 68,851 shares issued as of December 31, 2023 and 2022, respectively)	699	689
Additional paid-in capital	757,727	715,875
Treasury Stock at cost - 1,339 shares as of December 31, 2023 and 2022	(75,000)	(75,000)
Retained earnings (accumulated deficit)	133,503	(193,158)
Accumulated other comprehensive loss	(1,037)	(1,259)
Total stockholders’ equity	815,892	447,147
Total liabilities and stockholders’ equity	$ 1,651,149	$ 1,321,258

About Lantheus Holdings Inc

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; and Cardiolite, an injectable Tc-99m-labeled imaging agent. The company also offers AZEDRA, a radiotherapeutic therapy; Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; PNT2002 for pre-chemotherapy patients; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; and PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer. The company serves hospitals, independent diagnostic testing facilities, government facilities, integrated delivery networks, radiopharmacies, clinics, distirbutors, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; and FUJIFILM. The company was founded in 1956 and is based in Bedford, Massachusetts.

CEO	Ms. Mary Anne Heino
WEBSITE	lantheus.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	698

Lantheus Holdings Inc Frequently Asked Questions

What is the ticker symbol for Lantheus Holdings Inc? What does LNTH stand for in stocks?

LNTH is the stock ticker symbol of Lantheus Holdings Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Lantheus Holdings Inc (LNTH)?

As of Tue Apr 23 2024, market cap of Lantheus Holdings Inc is 4.41 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of LNTH stock?

You can check LNTH's fair value in chart for subscribers.

What is the fair value of LNTH stock?

You can check LNTH's fair value in chart for subscribers. The fair value of Lantheus Holdings Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Lantheus Holdings Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for LNTH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Lantheus Holdings Inc a good stock to buy?

The fair value guage provides a quick view whether LNTH is over valued or under valued. Whether Lantheus Holdings Inc is cheap or expensive depends on the assumptions which impact Lantheus Holdings Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for LNTH.

What is Lantheus Holdings Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, LNTH's PE ratio (Price to Earnings) is 13.51 and Price to Sales (PS) ratio is 3.4. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LNTH PE ratio will change depending on the future growth rate expectations of investors.